110 related articles for article (PubMed ID: 8586891)
1. Decrease of interferon-induced 2',5'-oligoadenylate synthetase activity in cirrhotic rat liver.
Miyajima I; Sata M; Uchimura Y; Suzuki H; Tanikawa K
Kansenshogaku Zasshi; 1995 Dec; 69(12):1383-8. PubMed ID: 8586891
[TBL] [Abstract][Full Text] [Related]
2. Interferon accumulation in cirrhotic rat liver.
Miyajima I; Sata M; Gondo K; Suzuki H; Tanikawa K
J Viral Hepat; 1996 Jan; 3(1):23-7. PubMed ID: 8736237
[TBL] [Abstract][Full Text] [Related]
3. A bioassay for serum interferon based on induction of 2'5'-oligoadenylate synthetase activity.
Uno K; Sato T; Takada Y; Fujioka K; Suginoshita Y; Kakimi K; Moriyasu F; Kishida T
J Interferon Cytokine Res; 1998 Dec; 18(12):1011-8. PubMed ID: 9877443
[TBL] [Abstract][Full Text] [Related]
4. [Mechanisms of the effect of interferon (IFN) therapy in patients with type B and C chronic hepatitis].
Karino Y
Hokkaido Igaku Zasshi; 1993 May; 68(3):297-309. PubMed ID: 7686526
[TBL] [Abstract][Full Text] [Related]
5. 2'-,5'-Oligoadenylate synthetase response ratio predicting virological response to PEG-interferon-alpha2b plus ribavirin therapy in patients with chronic hepatitis C.
Kim KI; Kim SR; Sasase N; Taniguchi M; Harada S; Kinoshita K; Kim SH; Akimoto Y; Shikata M; Kimura N; Izawa S; Ohtani A; Nakao K; Motojima M; Kinoshita M; Hirai M; Ohzu M; Hirooka T; Nabeshima S; Ishii F; Tanaka K; Hotta H
J Clin Pharm Ther; 2006 Oct; 31(5):441-6. PubMed ID: 16958821
[TBL] [Abstract][Full Text] [Related]
6. Localization of 2',5'-oligoadenylate synthetase and the enhancement of its activity with recombinant interferon-alpha A/D in the mouse brain.
Asada-Kubota M; Ueda T; Nakashima T; Kobayashi M; Shimada M; Takeda K; Hamada K; Maekawa S; Sokawa Y
Anat Embryol (Berl); 1997 Mar; 195(3):251-7. PubMed ID: 9084823
[TBL] [Abstract][Full Text] [Related]
7. [2'-5' oligoadenylate synthetase activity in patients with acute viral hepatitis and chronic type B hepatitis, and its clinical significance].
Komiyama T; Akaike M; Satomura K; Okumura H
Nihon Ika Daigaku Zasshi; 1991 Jun; 58(3):262-72. PubMed ID: 1715348
[TBL] [Abstract][Full Text] [Related]
8. Interferon-associated lymphocyte 2',5'-oligoadenylate synthetase in acute and chronic viral hepatitis.
Heathcote J; Kim YI; Yim CK; LeBrocq J; Read SE
Hepatology; 1989 Jan; 9(1):105-9. PubMed ID: 2461889
[TBL] [Abstract][Full Text] [Related]
9. Increased IFN-alpha-induced sensitivity but reduced reactivity of 2',5'-oligoadenylate synthetase (2,5AS) in trisomy 21 blood lymphocytes.
Gerdes AM; Hørder M; Bonnevie-Nielsen V
Clin Exp Immunol; 1993 Jul; 93(1):93-6. PubMed ID: 8324908
[TBL] [Abstract][Full Text] [Related]
10. Changes in hepatic nitrogen metabolism in isolated perfused liver during the development of thioacetamide-induced cirrhosis in rats.
Masumi S; Moriyama M; Kannan Y; Ohta M; Koshitani O; Sawamoto O; Sugano T
Toxicology; 1999 Jul; 135(1):21-31. PubMed ID: 10454221
[TBL] [Abstract][Full Text] [Related]
11. Subcellular distribution of 2',5'-oligoadenylate synthetase in differentiating Friend leukemia cells.
Mechti N; Affabris E; Romeo G; Lebleu B
Differentiation; 1985; 29(2):136-9. PubMed ID: 2412925
[TBL] [Abstract][Full Text] [Related]
12. Chloroquine impairs the interferon-induced antiviral state without affecting the 2',5'-oligoadenylate synthetase.
Chelbi-Alix MK; Thang MN
J Biol Chem; 1985 Jul; 260(13):7960-4. PubMed ID: 2409079
[TBL] [Abstract][Full Text] [Related]
13. [Modifications of the enzymatic content and morphology of the exocrine pancreas of rats with experimental hepatic cirrhosis induced by thioacetamide].
Santamaría Gil ME; de Andrés Loste MS; Fernández Alonso MC; González Fernández E; Blanco Varela FJ; Coca García MC; Caro-Patón Gómez A
An Med Interna; 1991 Dec; 8(12):601-4. PubMed ID: 1723629
[TBL] [Abstract][Full Text] [Related]
14. Cell cycle regulation (G1) by autocrine interferon and dissociation between autocrine interferon and 2',5'-oligoadenylate synthetase expression.
Wells V; Mallucci L
J Interferon Res; 1988 Dec; 8(6):793-802. PubMed ID: 2466091
[TBL] [Abstract][Full Text] [Related]
15. 2',5'-Oligoadenylate synthetase activity in the liver and peripheral blood mononuclear cells of chronic hepatitis patients.
Ogawa Y
Gastroenterol Jpn; 1988 Jun; 23(3):279-86. PubMed ID: 2456963
[TBL] [Abstract][Full Text] [Related]
16. Relationship of the effects of interferon on chronic hepatitis B and the induction of 2',5'-oligoadenylate synthetase.
Nishiguchi S; Kuroki T; Otani S; Takeda T; Hirota S; Shimizu Y; Nakajima S; Saito S; Shiomi S; Kobayashi K
Hepatology; 1989 Jul; 10(1):29-33. PubMed ID: 2472340
[TBL] [Abstract][Full Text] [Related]
17. Augmentation of interferon production after cell-differentiation of U937 cells by TPA.
Indoh T; Shirakawa S; Kubota T; Yashiki T; Isogai E; Fujii N
Microbiol Immunol; 1996; 40(9):675-9. PubMed ID: 8908614
[TBL] [Abstract][Full Text] [Related]
18. Identification by electron microscopy of the maturation steps in vaccinia virus morphogenesis inhibited by the interferon-induced enzymes, protein kinase (PKR), 2-5A synthetase, and nitric oxide synthase (iNOS).
Esteban M; Patiño C
J Interferon Cytokine Res; 2000 Oct; 20(10):867-77. PubMed ID: 11054274
[TBL] [Abstract][Full Text] [Related]
19. Alteration in growth regulation of hepatocytes in primary culture obtained from cirrhotic rat: poor response to transforming growth factor-beta 1 and interferons.
Kiso S; Kawata S; Tamura S; Ito N; Takaishi K; Shirai Y; Tsushima H; Matsuzawa Y
Hepatology; 1994 Nov; 20(5):1303-8. PubMed ID: 7523274
[TBL] [Abstract][Full Text] [Related]
20. The human 2',5'-oligoadenylate synthetase family: interferon-induced proteins with unique enzymatic properties.
Rebouillat D; Hovanessian AG
J Interferon Cytokine Res; 1999 Apr; 19(4):295-308. PubMed ID: 10334380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
